GlassScriptPhysician profile
Elise Burger
NPI 1558820944
$6,453.21
in general payments reported to CMS, 2019-2025
14 companies · $4,617 in 2025
The $4,617 reported for 2025 was more than what 89% of Dermatology providers received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $53.00 · 2021: $148 · 2022: $786 · 2023: $585 · 2024: $265 · 2025: $4,617.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,500 · Food and Beverage: $1,495 · Travel and Lodging: $1,372 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,500.00 |
| Food and Beverage | $1,494.51 |
| Travel and Lodging | $1,371.74 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $3,128.83 | 2022-2025 | Spevigo |
| Ucb Sa | $1,537.56 | 2025 | Bimzelx |
| E.R. Squibb & Sons, L.L.C. | $324.16 | 2022-2023 | Sotyktu |
| Journey Medical Corporation | $262.33 | 2022 | |
| Janssen Biotech, INC. | $249.61 | 2025 | Tremfya |
| Arcutis Biotherapeutics, INC. | $171.69 | 2023-2024 | Zoryve |
| Chiesi USA, INC. | $135.00 | 2025 | Filsuvez |
| Amgen INC. | $121.76 | 2021 | |
| Kerecis Limited | $118.26 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Sun Pharmaceutical Industries INC. | $108.13 | 2022 | |
| Genzyme Corporation | $80.83 | 2022 | |
| Vyne Pharmaceuticals INC. | $79.50 | 2020-2021 | |
| Integra Lifesciences Corporation | $76.11 | 2025 | Integra, Integra Dermal Regeneration Template |
| Dermavant Sciences, INC. | $59.44 | 2023 | Vtama |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elise Burger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.